InspireMD Inc (NSPR):企業の製品パイプライン分析

◆英語タイトル:InspireMD Inc (NSPR) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME8187PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥210,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥315,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, acute myocardial infarction, and saphenous vein graft coronary intervention. It utilizes MicroNet stent platform technology to develop its products and offers solutions for various disease conditions such as stenting, embolic showers, restenosis and late stent thrombosis. The company markets its products through a network of distributors in Israel and Germany. InspireMD is headquartered in Tel Aviv, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InspireMD Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
InspireMD Inc Company Overview
InspireMD Inc Company Snapshot
InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
InspireMD Inc – Pipeline Analysis Overview
InspireMD Inc – Key Facts
InspireMD Inc – Major Products and Services
InspireMD Inc Pipeline Products by Development Stage
InspireMD Inc Ongoing Clinical Trials by Trial Status
InspireMD Inc Pipeline Products Overview
CGuard Embolic Prevention System
CGuard Embolic Prevention System Product Overview
CGuard Embolic Prevention System Clinical Trial
MGuard Drug Eluting Stent
MGuard Drug Eluting Stent Product Overview
Next Gen CGuard – 5F
Next Gen CGuard – 5F Product Overview
NGuard
NGuard Product Overview
PVGuard Peripheral
PVGuard Peripheral Product Overview
RGuard Renal
RGuard Renal Product Overview
InspireMD Inc – Key Competitors
InspireMD Inc – Key Employees
InspireMD Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
InspireMD Inc, Recent Developments
Mar 10, 2020: InspireMD announces fourth quarter and year-end 2019 financial results
Jan 29, 2020: InspireMD announces successful live clinical case transmissions featuring CGuard EPS at the Leipzig Interventional Course (LINC) 2020
Jan 27, 2020: InspireMD’s CGuard Embolic Prevention System to be prominently featured in live case transmission at LINC, 28th to the 31st January 2020, in Leipzig, Germany
Jan 06, 2020: InspireMD announces strong preliminary fourth quarter 2019 revenue and reports inducement award under NYSE American Company Guide §711(a)
Dec 10, 2019: InspireMD announces planned leadership transition
Dec 10, 2019: InspireMD announces planned leadership transition
Nov 26, 2019: InspireMD reports updated positive CGuard EPS data presented at VEITH 2019
Nov 12, 2019: InspireMD announces third quarter 2019 financial results
Sep 09, 2019: InspireMD provides business update
Aug 06, 2019: InspireMD announces second quarter 2019 financial results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
InspireMD Inc Pipeline Products by Equipment Type
InspireMD Inc Pipeline Products by Indication
InspireMD Inc Ongoing Clinical Trials by Trial Status
InspireMD Inc, Key Facts
InspireMD Inc, Major Products and Services
InspireMD Inc Number of Pipeline Products by Development Stage
InspireMD Inc Pipeline Products Summary by Development Stage
InspireMD Inc Ongoing Clinical Trials by Trial Status
InspireMD Inc Ongoing Clinical Trials Summary
CGuard Embolic Prevention System - Product Status
CGuard Embolic Prevention System - Product Description
CGuard Embolic Prevention System - A Multicenter Italian Registry of Real World CAS with C-Guard Mesh Covered Stent: The IRONGUARD 2 Study
CGuard Embolic Prevention System - A Pivotal Study of the CGuard Carotid Stent System CARENET-III for Prevention of Stroke in Patients in the United States.
CGuard Embolic Prevention System - Carotid Artery Revascularization Using TransCarotid flow Reversal Cerebral Protection And CGUARD MicroNET-covered Embolic Prevention Stent System to Reduce Strokes in Patients with Symptoms or Signs of Cerebral Ischemia: TOP-GUARD Study
CGuard Embolic Prevention System - Independent Randomized Trial in Carotid Artery Revascularization Comparing the Stent (Acculink) Versus the Mesh Covered Stent (CGuard): The SIBERIA Trial
CGuard Embolic Prevention System - Long-term Outcomes of MicroNet-covered Stent Routine Use for Stroke Prevention in Symptomatic and Increased-risk Asymptomatic Carotid Stenosis Patients Requiring Revascularization by Neurovascular Team Decision: PARADIGM-EXTEND
CGuard Embolic Prevention System - OPTIMAl Endovascular Exclusion of High-risk Carotid Plaque Using the CGuard Stent in Patients with Symptoms or Signs of Carotid Stenosis-related Brain Injury: IVUS Controlled Investigator Initiated Multcentric Multi-specialty Study
CGuard Embolic Prevention System - Prospective Evaluation of All-comer Percutaneous Carotid Revascularization In Symptomatic and Increased-risk Asymptomatic Carotid Artery Stenosis
CGuard Embolic Prevention System - Prospective Observational Study of CGuard MicroNet Covered Stent System Use as a Flow Diverter in the Endovascular Exclusion of Carotid Artery Aneurysms. (CGuard Divert-and-HEAL C-HEAL)
CGuard Embolic Prevention System - Prospective Observational Study of Procedures with MicroNet Covered Stent Use to Treat Increased Risk Lesions in Arterial Locations Beyond the Carotid Bifurcation - FLOW-Guard Study
MGuard Drug Eluting Stent - Product Status
MGuard Drug Eluting Stent - Product Description
Next Gen CGuard - 5F - Product Status
Next Gen CGuard - 5F - Product Description
NGuard - Product Status
NGuard - Product Description
PVGuard Peripheral - Product Status
PVGuard Peripheral - Product Description
RGuard Renal - Product Status
RGuard Renal - Product Description
InspireMD Inc, Key Employees
InspireMD Inc, Other Locations
InspireMD Inc, Subsidiaries
Glossary

★海外企業調査レポート[InspireMD Inc (NSPR):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hsh Nordbank Private Banking:企業の戦略・SWOT・財務分析
    Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • General Electric Co (GE):企業の財務・戦略的SWOT分析
    General Electric Co (GE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ficosa International SA:企業の戦略・SWOT・財務情報
    Ficosa International SA - Strategy, SWOT and Corporate Finance Report Summary Ficosa International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PT Sinar Mas Multiartha Tbk (SMMA):企業の財務・戦略的SWOT分析
    PT Sinar Mas Multiartha Tbk (SMMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • PATRIZIA Immobilien AG:企業のM&A・事業提携・投資動向
    PATRIZIA Immobilien AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PATRIZIA Immobilien AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Harman International Industries Inc:企業の戦略的SWOT分析
    Harman International Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Illinois Municipal Electric Agency:企業の戦略的SWOT分析
    Illinois Municipal Electric Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Ackermans & Van Haaren NV:戦略・SWOT・企業財務分析
    Ackermans & Van Haaren NV - Strategy, SWOT and Corporate Finance Report Summary Ackermans & Van Haaren NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • UTStarcom Holdings Corp. (UTSI):企業の財務・戦略的SWOT分析
    UTStarcom Holdings Corp. (UTSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Websol Energy System Ltd (WEBELSOLAR):企業の財務・戦略的SWOT分析
    Summary Websol Energy System Ltd (Websol) is an alternate energy company that offers manufacturing of photovoltaic crystalline solar cells and the related modules. The company offers products such as pv solar cell and pv solar module. Its pv solar cell includes multi-crystalline mono crystalline 5bb …
  • The AES Corporation (AES):電力:M&Aディール及び事業提携情報
    Summary The AES Corporation (AES) is a diversified power company, which owns and operates power generating facilities. The company generates electricity through diverse fuel sources such as gas, fuel oil and coal; and renewable sources such as wind, hydro, biomass and solar. It sells the electricity …
  • Kaiser Foundation Health Plan of Washington:企業の戦略的SWOT分析
    Kaiser Foundation Health Plan of Washington - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Public Service Enterprise Group Inc:企業の発電所・SWOT分析2018
    Public Service Enterprise Group Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Innate Immunotherapeutics Ltd (IIL):製薬・医療:M&Aディール及び事業提携情報
    Summary Innate Immunotherapeutics Ltd (Innate Immunotherapeutics), formerly Innate Therapeutics Ltd is a pharmaceutical company that develops therapeutic drugs for the treatment of cancer and infectious diseases. The company utilizes immunomodulator microparticle technology. It develops lead drug ca …
  • Callaway Golf Co (ELY):企業の財務・戦略的SWOT分析
    Callaway Golf Co (ELY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CLP Holdings Ltd (2)-エネルギー分野:企業M&A・提携分析
    Summary CLP Holdings Limited (CLP) is an investor and operator in the energy sector of Asia Pacific region. The company invests in power generation, transmission and distribution, and electricity and gas retail activities. Its portfolio includes equity generating and purchase capacities. CLP’s gener …
  • Isagen SA ESP:企業の戦略的SWOT分析
    Isagen SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Honshu Chemical Industry Co Ltd (4115):企業の財務・戦略的SWOT分析
    Honshu Chemical Industry Co Ltd (4115) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • USG Corporation:企業の戦略・SWOT・財務情報
    USG Corporation - Strategy, SWOT and Corporate Finance Report Summary USG Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • London North West Healthcare NHS Trust:企業の戦略的SWOT分析
    London North West Healthcare NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆